Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

PURPOSE: To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of ≤60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, thi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychiatr Dis Treat
Autori principali: Novick, Diego, Montgomery, William, Haro, Josep Maria, Moneta, Maria Victoria, Zhu, Gang, Yue, Li, Hong, Jihyung, Dueñas, Héctor, Brugnoli, Roberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770062/
https://ncbi.nlm.nih.gov/pubmed/26966361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S100675
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi